As of June 2024 Calithera Biosciences has a market cap of $0.04 Million. This makes Calithera Biosciences the world's 8428th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.04 M | -66.67% |
2023 | $0.14 M | -99.08% |
2022 | $15.86 M | -68.18% |
2021 | $49.84 M | -85.61% |
2020 | $0.34 B | -4.47% |
2019 | $0.36 B | 132.89% |
2018 | $0.15 B | -47.43% |
2017 | $0.29 B | 339.52% |
2016 | $67.39 M | -51.74% |
2015 | $0.13 B | -61.47% |
2014 | $0.36 B |
On Jun 1st, 2024 the market cap of Calithera Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $80.07 B | 164,331,907.57% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | 941,780.28% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | $11.76 M | 24,042.37% | ๐บ๐ธ USA |